Category: Clinical Breakthroughs
-
Investigating the Financial Burden of Cancer Drugs on Medicare Patients
The rising cost of targeted oral anticancer medications may put a substantial financial burden on individual patients enrolled in Medicare’s prescription drug benefit program, Part D, according to a new study.
-
Cosmetic Complaints Climb, But Products Still on Market
Consumer complaints for cosmetic products have more than doubled, but consumers may remain at risk because the industry receives little regulatory scrutiny, according to new research.
-
Stem Cell Transplant May Not Benefit Double-Hit Lymphoma Patients
A new study finds that patients with double-hit lymphoma who received autologous stem cell transplantation saw no survival benefit, compared to patients who did not undergo the procedure.
-
New Cancer Drug Can Prevent Reactions to Common Airborne Allergens
A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.
-
Scientists Use Wearables to Track Patient Data
Northwestern scientists and clinicians are using wearable technology to gather a wealth of novel information about patients and to devise innovative ways to treat and prevent disease.
-
Combined Strategies Better Assess Heart Disease Risks
A new strategy combining five separate tests provided a significantly better risk assessment of cardiovascular disease among adults, compared to traditional measures, according to a study published in Circulation.
-
Cold Virus, Stem Cells Tested to Destroy Deadly Brain Cancer
An investigational neural stem cell therapy that works with a common cold virus to seek out and attack malignant glioma is being tested at Northwestern Medicine in a phase I clinical trial.
-
Evaluating Active Surveillance in Prostate Cancer
Younger men with prostate cancer had a decreased risk of cancer progression while under active surveillance, compared to men older than 60, according to a recent study.
-
Leaving Segregated Neighborhoods Reduces Blood Pressure for Blacks
Systolic blood pressure for African-American patients dropped between one to five points when they moved to less segregated neighborhoods, according to a new study.
-
First Spherical Nucleic Acid Drug Injected into Humans Targets Brain Cancer
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
